Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Mesothelioma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT01867710 2019-07-05

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Phase 2 Completed

164 enrolled 22 charts

Genitourinary

Hyperaldosteronism, Prostatic Neoplasms

NCT00531284 2017-08-15

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Phase 1/2 Completed

184 enrolled 36 charts

GenitourinaryGynecologicLymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

21 enrolled

Genitourinary

Prostatic Neoplasms

NCT01188187 2016-10-14

SYNERGY

Phase 3 Completed

1,022 enrolled

Genitourinary

Prostatic Neoplasms

NCT00473746 2014-04-29

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Phase 1/2 Completed

66 enrolled 22 charts

Genitourinary

Prostatic Neoplasms

NCT00473512 2014-03-27

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Phase 1/2 Completed

54 enrolled 20 charts

Genitourinary

Prostatic Neoplasms

Clinical Trials

MK-5684-01A

OMAHA-003

MK-5684-004

MK-5684-005

KEYNOTE-365

MK-5684-001

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

KEYNOTE-921

KEYNOTE-921

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

PEGAZUS

SYNERGY

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy